Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
2026-09-19

Regulatory Watch

AI-synthesized intelligence from CBN, FIRS, CAC, NAFDAC, SON, and NEPZA — so your business stays ahead of regulatory change.

September 19, 2026 6 updates 2 sources
NAFDAC is intensifying pharmaceutical and clinical trial oversight through new mandatory training, a pharmacist reserve corps, and enforcement actions against non-compliant importers and marketers. For Nigerian SMBs in healthcare, pharma distribution, and related sectors, this means stricter compliance requirements and heightened scrutiny of product sourcing and marketing.
What's being regulated
Pharmaceuticals Healthcare Importation & Distribution Clinical Trials Food & Drug Regulation Export (Fish Farming)
Latest regulatory changes
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharma manufacturing and chemistry should note NAFDAC's focus on innovation and affordability, potentially influencing future regulatory pathways for new products.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to enhance regulatory capacity.
This may lead to more frequent inspections and faster response to regulatory issues, requiring SMBs to maintain higher compliance standards.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
New dates announced for mandatory training on clinical trial regulations for stakeholders.
SMBs involved in clinical trials must ensure their staff attend this training to remain compliant and avoid penalties.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, and its products due to regulatory violations.
Importers and distributors must immediately stop handling products from this company and verify their supply chains to avoid legal consequences.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on a watchlist pending investigation.
Retailers, wholesalers, and PPMVs should exercise caution and possibly suspend sales of these products until investigations conclude.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
Guide on registering fish farms with NEPC for export purposes.
SMBs in aquaculture can leverage this guide to access export markets, but must comply with NEPC registration and export standards.
What this means for your business
Increased regulatory scrutiny on pharmaceutical imports and distribution.
Mandatory training for clinical trial stakeholders indicates tighter oversight.
Blacklisting and watchlisting of companies signal zero tolerance for non-compliance.
NAFDAC's capacity building through pharmacist reserve may lead to more inspections.
Export opportunities for fish farmers through NEPC registration.
What to do next
1 Verify all pharmaceutical products against NAFDAC blacklists and watchlists before importation or distribution.
2 Ensure staff involved in clinical trials attend the mandatory NAFDAC/NHREC training.
3 Review supply chains to avoid products from blacklisted companies like Ayrtons Saunders Ltd.
4 Monitor NAFDAC alerts regularly for updates on watchlisted products.
5 For fish farmers, initiate NEPC registration to access export markets.
← Previous edition
Browse archive
Next edition →

Never miss a regulatory change

From CBN monetary policy to FIRS tax circulars — our AI Workspace monitors the regulatory landscape so you don't have to.

Create free account